MHC class I cross-presentation by dendritic cells counteracts viral immune evasion

Frontiers in Immunology

Volumn 3, Issue NOV, 2012, Pages

  Nopora, Katrin ^a   Bernhard, Caroline A ^a   Ried, Christine ^a   Castello, Alejandro A ^a,d   Murphy, Kenneth M ^b   Marconi, Peggy ^c   Koszinowski, Ulrich ^a   Brocker, Thomas ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FERRARA   (Italy)

^d UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

Author keywords

Cross priming; Dendritic cells; Immune evasion

Indexed keywords

EID: 84874215696     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00348     Document Type: Article

References (61)

1. Allan, R. S., Smith, C. M., Belz, G. T., van Lint, A. L., Wakim, L. M., Heath, W., et al. (2003). Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science 301, 1925-1928.
2. Andrews, D. M., Andoniou, C. E., Granucci, F., Ricciardi-Castagnoli, P., and Degli-Esposti, M. A. (2001). Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat. Immunol. 2, 1077-1084.
3. Bedoui, S., Whitney, P. G., Waithman, J., Eidsmo, L., Wakim, L., Caminschi, I., et al. (2009). Cross-presentation of viral and self antigens by skinderived CD103+ dendritic cells. Nat. Immunol. 10, 488-495.
4. Belz, G. T., Shortman, K., Bevan, M. J., and Heath, W. R. (2005). CD8alpha+ dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo. J. Immunol. 175, 196-200.
5. Belz, G. T., Smith, C. M., Eichner, D., Shortman, K., Karupiah, G., Carbone, F. R., et al. (2004a). Cutting edge: conventional CD8 alpha+ dendritic cells are generally involved in priming CTL immunity to viruses. J. Immunol. 172, 1996-2000.
6. Belz, G. T., Smith, C. M., Kleinert, L., Reading, P., Brooks, A., Shortman, K., et al. (2004b). Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc. Natl. Acad. Sci. U.S.A. 101, 8670-8675.
7. Benedict, C. A., Loewendorf, A., Garcia, Z., Blazar, B. R., and Janssen, E. M. (2008). Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PDL1/PD-1 pathway. J. Immunol. 180, 4836-4847.
8. Coffin, R. S., Thomas, S. K., Thomas, N. S., Lilley, C. E.,Pizzey, A. R.,Griffiths, C. H., et al. (1998). Pure populations of transduced primary human cells can be produced using GFP expressing herpes virus vectors and flow cytometry. Gene Ther. 5, 718-722.
9. den Haan, J. M., Lehar, S. M., and Bevan, M. J. (2000). CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192, 1685-1696.
10. Edelson, B. T., Kc, W., Juang, R., Kohyama, M., Benoit, L. A., Klekotka, P. A., et al. (2010). Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. J. Exp. Med. 207, 823-836.
11. Engelmayer, J., Larsson, M., Subklewe, M., Chahroudi, A., Cox, W. I., Steinman, R. M., et al. (1999). Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 163, 6762-6768.
12. Gold, M. C., Munks, M. W., Wagner, M., McMahon, C. W., Kelly, A., Kavanagh, D. G., et al. (2004). Murine cytomegalovirus interference with antigen presentation has little effect on the size or the effector memory phenotype of the CD8 T cell response. J. Immunol. 172, 6944-6953.
13. Hardwicke, M. A., and Sandri-Goldin, R. M. (1994). The herpes simplex virus regulatory protein ICP27 contributes to the decrease in cellular mRNA levels during infection. J. Virol. 68, 4797-4810.
14. Hardy, W. R., and Sandri-Goldin, R. M. (1994). Herpes simplex virus inhibits host cell splicing, and regulatory protein ICP27 is required for this effect. J. Virol. 68, 7790-7799.
15. Heath, W. R., and Carbone, F. R. (2001). Cross-presentation in viral immunity and self-tolerance. Nat. Rev. Immunol. 1, 126-134.
16. Hickman, H. D., Takeda, K., Skon, C. N., Murray, F. R., Hensley, S. E., Loomis, J.,et al. (2008). Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes. Nat. Immunol. 9, 155-165.
17. Hildner, K., Edelson, B. T., Purtha, W. E., Diamond, M., Matsushita, H., Kohyama, M., et al. (2008). Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 322, 1097-1100.
18. Hill, A., Jugovic, P., York, I., Russ, G., Bennink, J., Yewdell, J., et al. (1995). Herpes simplex virus turns off the TAP to evade host immunity. Nature 375, 411-415.
19. Hill, A. B., Barnett, B. C., McMichael, A. J., and McGeoch, D. J. (1994). HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2. J. Immunol. 152, 2736-2741.
20. Hinkley, S., Ambagala, A. P., Jones, C. J., and Srikumaran, S. (2000). A vhslike activity of bovine herpesvirus-1. Arch. Virol. 145, 2027-2046.
21. Iyoda, T., Shimoyama, S., Liu, K., Omatsu, Y., Akiyama, Y., Maeda, Y., et al. (2002). The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195, 1289-1302.
22. Jirmo, A. C., Nagel, C. H., Bohnen, C., Sodeik, B., and Behrens, G. M. (2009). Contribution of direct and cross-presentation to CTL immunity against herpes simplex virus 1. J. Immunol. 182, 283-292.
23. Kavanagh, D. G., Gold, M. C., Wagner, M., Koszinowski, U. H., and Hill, A. B. (2001). The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion. J. Exp. Med. 194, 967-978.
24. Kerksiek, K. M., Niedergang, F., Chavrier, P., Busch, D. H., and Brocker, T. (2005). Selective Rac1 inhibition in dendritic cells diminishes apoptotic cell uptake and cross-presentation in vivo. Blood 105, 742-749.
25. 34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J. 16, 685-694.
26. Koppers-Lalic, D., Rijsewijk, F. A., Verschuren, S. B., van Gaans-Van den Brink, J. A., Neisig, A., Ressing, M. E., et al. (2001). The UL41-encoded virion host shutoff (vhs) protein and vhs-independent mechanisms are responsible for down-regulation of MHC class I molecules by bovine herpesvirus 1. J. Gen. Virol. 82, 2071-2081.
27. Krisky, D. M., Marconi, P. C., Oligino, T. J., Rouse, R. J., Fink, D. J., Cohen, J. B., et al. (1998). Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications. Gene Ther. 5, 1517-1530.
28. Kruse, M., Rosorius, O., Kratzer, F., Stelz, G., Kuhnt, C., Schuler, G., et al. (2000). Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited Tcell stimulatory capacity. J. Virol. 74, 7127-7136.
29. Kurts, C., Miller, J. F., Subramaniam, R. M., Carbone, F. R., and Heath, W. R. (1998). MHC class I-restricted cross-presentation is biased towards high dose Ag and those released during cellular destruction. J. Exp. Med. 188, 409-414.
30. Lauterbach, H., Kerksiek, K. M., Busch, D. H., Berto, E., Bozac, A., Mavromara, P., et al. (2004). Protection from bacterial infection by a single vaccination with replicationdeficient mutant herpes simplex virus type 1. J. Virol. 78, 4020-4028.
31. Leib, D. A., Harrison, T. E., Laslo, K. M., Machalek, M. A., Moorman, N. J., and Virgin, H. W. (1999). Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J. Exp. Med. 189, 663-672.
32. Loewendorf, A., Kruger, C., Borst, E. M., Wagner, M., Just, U., and Messerle, M. (2004). Identification of a mouse cytomegalovirus gene selectively targeting CD86 expression on antigen-presenting cells. J. Virol. 78, 13062-13071.
33. Luckashenak, N.,Schroeder, S.,Endt, K., Schmidt, D., Mahnke, K., Bachmann, M. F., et al. (2008). Constitutive cross presentation of tissue antigens by dendritic cells controls CD8+ T cell tolerance in vivo. Immunity 28, 521-532.
34. Lukens, M. V., Kruijsen, D., Coenjaerts, F. E., Kimpen, J. L., and van Bleek, G. M. (2009). Respiratory syncytial virus-induced activation and migration of respiratory dendritic cells and subsequent antigen presentation in the lung-draining lymph node. J. Virol. 83, 7235-7243.
35. Mikloska, Z., Bosnjak, L., and Cunningham, A. L. (2001). Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1. J. Virol. 75, 5958-5964.
36. Mogensen,T. H.,Melchjorsen,J.,Malmgaard, L., Casola, A., and Paludan, S. R. (2004). Suppression of proinflammatory cytokine expression by herpes simplex virus type 1. J. Virol. 78, 5883-5890.
37. Mueller, S. N., Heath, W., McLain, J. D., Carbone, F. R., and Jones, C. M. (2002). Characterization of two TCR transgenic mouse lines specific for herpes simplex virus. Immunol. Cell Biol. 80, 156-163.
38. Munks, M. W., Pinto, A. K., Doom, C. M., and Hill, A. B. (2007). Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection. J. Immunol. 178, 7235-7241.
39. Neuenhahn, M., Kerksiek, K. M., Nauerth, M., Suhre, M. H., Schiemann, M., Gebhardt, F. E., et al. (2006). CD8alpha+ dendritic cells are required for efficient entry of Listeria monocytogenes into the Spleen. Immunity 25, 619-630.
40. Norbury, C. C., Princiotta, M. F., Bacik, I., Brutkiewicz, R. R., Wood, P., Elliott, T., et al. (2001). Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivo. J. Immunol. 166, 4355-4362.
41. Pircher, H., Burki, K., Lang, R., Hengartner, H., and Zinkernagel, R. M. (1989). Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342, 559-561.
42. Prechtel, A. T., Turza, N. M., Kobelt, D. J., Eisemann, J. I., Coffin, R. S., McGrath, Y., et al. (2005). Infection of mature dendritic cells with herpes simplex virus type 1 dramatically reduces lymphoid chemokinemediatedmigration. J.Gen.Virol.86, 1645-1657.
43. Reusch U., Muranyi, W., Lucin, P., Burgert, H. G., Hengel, H., and Koszinowski, U. H. (1999). A cytomegalovirus glycoprotein reroutes MHC class I complexes to lysosomes for degradation. EMBO J. 18, 1081-1091.
44. Rice, S. A., Long, M. C., Lam, V., Schaffer, P. A., and Spencer, C. A. (1995). Herpes simplex virus immediateearly protein ICP22 is required for viral modification of host RNA polymerase II and establishment of the normal viral transcription program. J. Virol. 69, 5550-5559.
45. Salio, M., Cella, M., Suter, M., and Lanzavecchia, A. (1999). Inhibition of dendritic cell maturation by herpes simplex virus. Eur. J. Immunol. 29, 3245-3253.
46. Samady, L., Costigliola, E., MacCormac, L., McGrath, Y., Cleverley, S., Lilley, C. E., et al. (2003). Deletion of the virion host shutoff protein (vhs) from herpes simplex virus (HSV) relieves the viral block to dendritic cell activation: potential of vhs-HSV vectors for dendritic cellmediated immunotherapy. J. Virol. 77, 3768-3776.
47. Shortman, K., and Heath, W. R. (2010). The CD8+ dendritic cell subset. Immunol. Rev. 234, 18-31.
48. Sigal, L. J., Crotty, S., Andino, R., and Rock, K. L. (1999). Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 398, 77-80.
49. Smiley, J. R. (2004). Herpes simplex virus virion host shutoff protein: immune evasion mediated by a viral RNase? J. Virol. 78, 1063-1068.
50. Smith, C. M., Belz, G. T., Wilson, N. S., Villadangos, J. A., Shortman, K., Carbone, F. R., et al. (2003). Cutting edge: conventional CD8 alpha+ dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1. J. Immunol. 170, 4437-4440.
51. Snyder, C. M.,Allan, J. E., Bonnett, E. L., Doom, C. M., and Hill, A. B. (2010). Cross-presentation of a spreaddefective MCMV is sufficient to prime the majority of virus-specific CD8+ T cells. PLoS ONE 5, e9681. doi:10.1371/journal.pone.0009681
52. Song, B., Yeh, K. C., Liu, J., and Knipe, D. M. (2001). Herpes simplex virus gene products required for viral inhibition of expression of G1-phase functions. Virology 290, 320-328.
53. Spencer, C. A., Dahmus, M. E., and Rice, S. A. (1997). Repression of host RNA polymerase II transcription by herpes simplex virus type 1. J. Virol. 71, 2031-2040.
54. Strelow, L. I., and Leib, D. A. (1996). Analysis of conserved domains of UL41 of herpes simplex virus type 1 in virion host shutoff and pathogenesis. J. Virol. 70, 5665-5667.
55. Tigges, M. A., Leng, S., Johnson, D. C., and Burke, R. L. (1996). Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled. J. Immunol. 156, 3901-3910.
56. Torti, N., Walton, S. M., Murphy, K. M., and Oxenius, A. (2011). Batf3 transcription factor-dependent DC subsets in murine CMV infection: differential impact on T-cell priming and memory inflation. Eur. J. Immunol. 41, 2612-2618.
57. Tortorella, D., Gewurz, B. E., Furman, M. H., Schust, D. J., and Ploegh, H. L. (2000). Viral subversion of the immune system. Annu. Rev. Immunol. 18, 861-926.
58. Wagner, M., Gutermann, A., Podlech, J., Reddehase, M. J., and Koszinowski, U. H. (2002). Major histocompatibility complex class I allele-specific Nopora et al. Cross-priming enhances generation of virus-specific CTL cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J. Exp. Med. 196, 805-816.
59. Wilson, N. S., Behrens, G. M., Lundie, R. J., Smith, C. M., Waithman, J., Young, L.,et al.(2006).Systemicactivation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat. Immunol. 7, 165-172.
60. Yewdell, J. W., and Hill, A. B. (2002). Viral interference with antigen presentation. Nat. Immunol. 3, 1019-1025.
61. Ziegler, H., Thale, R. , Lucin, P. , Muranyi, W., Flohr, T., Hengel, H., et al. (1997). A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cisGolgi compartments. Immunity 6, 57-66.